Modification of norepinephrine synthesis in intact tissue dy drugs and during short-term adrenergic nerve stimulation.
D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D003653:Decarboxylation; D004347:Drug Interactions; D004558:Electric Stimulation; D006168:Guinea Pigs; D007700:Kinetics; D008995:Monoamine Oxidase / Q000032:analysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000201:enzymology; D009638:Norepinephrine / Q000096:biosynthesis* / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D011621:Pteridines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013312:Stress, Physiological; D013564:Sympathetic Nervous System / Q000378:metabolism*; D013566:Sympathomimetics / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis / Q000037:antagonists & inhibitors
D001949:Bretylium Compounds; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D011621:Pteridines; D013566:Sympathomimetics; D014316:Tritium; D014443:Tyrosine; D012110:Reserpine; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase; D008995:Monoamine Oxidase; D009638:Norepinephrine